Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Suction versus water-seal chest tube management for traumatic hemothorax/hemopneumothorax

Official title: SUS-HPTX Trial: Suction vs Underwater Seal for HemoPneumoThoraX Trial

Run by Vanderbilt University Medical Center · NCT07551791 · Data updated 2026-11-12

This trial will try whether starting chest tubes on suction or keeping them on a water seal helps adults with traumatic hemothorax or hemopneumothorax get their tubes out sooner and recover faster.

More Traumatic Brain Injury trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedApril 14, 2026
Main results expectedOctober 2026
Study endsMarch 2027
Registry record updatedJune 2, 2026
Trial IDNCT07551791 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults admitted to the trauma service with hemothorax or hemopneumothorax who require chest tube placement and meet the enrollment criteria are the ideal candidates.

Probably not a fit

People who are under 18, pregnant, incarcerated, or had a chest tube placed before CT (and other excluded patients) would not be eligible and therefore would not directly benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized trial at a large trauma center comparing initial chest tube management with continuous negative-pressure suction versus water seal in adults with traumatic hemothorax or hemopneumothorax. Eligible patients are admitted to the trauma service and require tube thoracostomy; key exclusions include age under 18, pregnancy, incarceration, or chest tube placement prior to CT. Participants are randomized to one of the two standard-of-care drainage strategies and followed for chest tube duration, pleural-space complications, and hospital length of stay. The trial expands on prior work (the SEAL IT trial) by including patients with significant hemothorax who were previously excluded.

Why it matters

Potential benefit: If successful, this approach could shorten chest tube duration and reduce hospital time and complications for patients with traumatic hemothorax or hemopneumothorax.

How similar studies have gone: Previous studies have been mixed, but the predecessor SEAL IT trial found that initial water seal shortened chest tube duration for traumatic pneumothorax without more complications, though that trial excluded patients with significant hemothorax.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Admitted to trauma service
* Patient has hemothorax or hemopneumothorax requiring chest tube

Exclusion Criteria:

* Less than 18 years old, pregnant, prisoner, chest tube placed prior to CT scan

Where it's running

  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.